These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24449443)

  • 41. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design.
    Sharma A; Singh AP; Harikumar SL
    Drug Dev Ind Pharm; 2020 Feb; 46(2):329-342. PubMed ID: 31976777
    [No Abstract]   [Full Text] [Related]  

  • 42. Transdermal permeation of drugs with differing lipophilicity: Effect of penetration enhancer camphor.
    Xie F; Chai JK; Hu Q; Yu YH; Ma L; Liu LY; Zhang XL; Li BL; Zhang DH
    Int J Pharm; 2016 Jun; 507(1-2):90-101. PubMed ID: 27154251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Infrared spectroscopic study of lipid interaction in stratum corneum treated with transdermal absorption enhancers.
    Obata Y; Utsumi S; Watanabe H; Suda M; Tokudome Y; Otsuka M; Takayama K
    Int J Pharm; 2010 Apr; 389(1-2):18-23. PubMed ID: 20079819
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats.
    Mahmoud MO; Aboud HM; Hassan AH; Ali AA; Johnston TP
    J Control Release; 2017 May; 254():10-22. PubMed ID: 28344015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactions between novel terpenes and main components of rat and human skin: mechanistic view for transdermal delivery of propranolol hydrochloride.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M; Ali A
    Curr Drug Deliv; 2011 Mar; 8(2):213-24. PubMed ID: 21235472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemical enhancers for transdermal drug transport.
    Bauerová K; Matusová D; Kassai Z
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):85-94. PubMed ID: 11554439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use.
    Amnuaikit C; Ikeuchi I; Ogawara K; Higaki K; Kimura T
    Int J Pharm; 2005 Jan; 289(1-2):167-78. PubMed ID: 15652209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Natural Ingredients of Transdermal Drug Delivery Systems as Permeation Enhancers of Active Substances through the
    Schafer N; Balwierz R; Biernat P; Ochędzan-Siodłak W; Lipok J
    Mol Pharm; 2023 Jul; 20(7):3278-3297. PubMed ID: 37279070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Mild Hyperthermia on Transdermal Absorption of Nicotine from Patches.
    Panda A; Sharma PK; Narasimha Murthy S
    AAPS PharmSciTech; 2019 Jan; 20(2):77. PubMed ID: 30635802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biodegradable derivatives of tranexamic acid as transdermal permeation enhancers.
    Vávrová K; Hrabálek A; Dolezal P; Holas T; Klimentová J
    J Control Release; 2005 May; 104(1):41-9. PubMed ID: 15866333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transdermal delivery of ketorolac.
    Amrish C; Kumar SP
    Yakugaku Zasshi; 2009 Mar; 129(3):373-9. PubMed ID: 19252396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
    Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
    J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Sensitivity of In Vitro Permeation Tests to Chemical Penetration Enhancer Concentration Changes in Fentanyl Transdermal Delivery Systems.
    Shin SH; Srivilai J; Ibrahim SA; Strasinger C; Hammell DC; Hassan HE; Stinchcomb AL
    AAPS PharmSciTech; 2018 Oct; 19(7):2778-2786. PubMed ID: 30084070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transdermal delivery of valsartan: I. Effect of various terpenes.
    Rizwan M; Aqil M; Ahad A; Sultana Y; Ali MM
    Drug Dev Ind Pharm; 2008 Jun; 34(6):618-26. PubMed ID: 18568912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percutaneous permeation enhancement by terpenes: mechanistic view.
    Sapra B; Jain S; Tiwary AK
    AAPS J; 2008; 10(1):120-32. PubMed ID: 18446512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Skin permeation enhancement of diclofenac by fatty acids.
    Kim MJ; Doh HJ; Choi MK; Chung SJ; Shim CK; Kim DD; Kim JS; Yong CS; Choi HG
    Drug Deliv; 2008 Aug; 15(6):373-9. PubMed ID: 18686081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.
    Kanikkannan N; Kandimalla K; Lamba SS; Singh M
    Curr Med Chem; 2000 Jun; 7(6):593-608. PubMed ID: 10702628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.